INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $97,000 | +29.3% | 12,400 | +8.8% | 0.01% | +30.0% |
| Q1 2017 | $75,000 | -5.1% | 11,400 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $79,000 | -60.3% | 11,400 | -46.7% | 0.01% | -63.0% |
| Q3 2016 | $199,000 | 0.0% | 21,400 | -0.7% | 0.03% | +8.0% |
| Q2 2016 | $199,000 | +4.2% | 21,550 | -1.8% | 0.02% | +8.7% |
| Q1 2016 | $191,000 | -52.7% | 21,950 | -63.5% | 0.02% | -50.0% |
| Q4 2015 | $404,000 | – | 60,170 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |